WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, … WebLonger term, while Biotheranostics currently markets its products only in the US, Hologic plans to leverage its own sales and marketing teams to promote them internationally. Also in the long run, Hologic may configure Biotheranostics' tests to run on Hologic's Panther Fusion platform, Thornal added.
Biotheranostics, Inc. A Hologic Company
WebOncology Account Executive Diagnostics at Biotheranostics - A Hologic Company Hologic, Inc. Mar 2024 - Present 2 years 2 months. Texas, United States • Multiple Sales Awards 2024, President ... WebJan 5, 2024 · Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated about $33 million ... salem school district nh employment
Hologic, Inc. - Hologic to Acquire Biotheranostics, Leader
WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in oncology. Visit Hologic.com . WebApr 12, 2024 · In February, Hologic acquired Biotheranostics Inc. -- a leader in molecular oncology -- for around $230 million. The acquisition allows Hologic to tap into the rapidly-growing oncology market. WebMar 30, 2024 · The expanded lab will be the new headquarters for Biotheranostics, a San Diego-based company acquired by Hologic in 2024 for $230 million. The new lab increases the Biothernostic’s testing capacity for its Breast Cancer Index and CancerTYPE ID tests by four times and will feature a new R&D space to explore additional tests. things to do when ur bored on a laptop